A Randomized, Double-blind, Multi-center, Multi-factorial, Phase 2 Trial to Evaluate the Efficacy and Safety of S-Amlodipine/Telmisartan Combined or Alone and Select Better Dose of CKD-828 in Patients With Essential Hypertension

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2010
The aim of this trial is to determine the best dose combination of S‐Amlodipine and Telmisartan as compared to monotherapy by assessing the blood pressure lowering effects of a once daily regimen of various combinations of S‐Amlodipine and Telmisartan, compared to their monotherapy components and placebo, in patients with stage I or II essential hypertension(a mean seated cuff diastolic blood pressure >=95 and <=115 mmHg). http://clinicaltrials.gov/ct2/show/NCT01128322
Epistemonikos ID: 613a1d88f557f608006d5996de4a3f6097a782f8
First added on: May 05, 2024